Leukemia, Promyelocytic, Acute
"Leukemia, Promyelocytic, Acute" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Descriptor ID |
D015473
|
| MeSH Number(s) |
C04.557.337.539.275.700
|
| Concept/Terms |
Leukemia, Promyelocytic, Acute- Leukemia, Promyelocytic, Acute
- Leukemia, Acute Promyelocytic
- Leukemia, Myeloid, Acute, M3
- M3 ANLL
- ANLL, M3
- Myeloid Leukemia, Acute, M3
- Progranulocytic Leukemia
- Promyelocytic Leukemia, Acute
- AML M3
- Acute Promyelocytic Leukemia
- Acute Promyelocytic Leukemias
- Leukemia, Progranulocytic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Promyelocytic, Acute".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Promyelocytic, Acute".
This graph shows the total number of publications written about "Leukemia, Promyelocytic, Acute" by people in this website by year, and whether "Leukemia, Promyelocytic, Acute" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 5 | 3 | 8 |
| 2018 | 7 | 0 | 7 |
| 2019 | 4 | 0 | 4 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Leukemia, Promyelocytic, Acute" by people in Profiles.
-
Sudden death of a SARS-CoV-2 patient with NPM1 + acute myeloid leukemia mimicking acute promyelocytic leukemia. Int J Lab Hematol. 2021 06; 43(3):341-342.
-
[Fever, loss of vision and acute promyelocytic leukemia at the pandemic ward]. Ugeskr Laeger. 2020 07 13; 182(29).
-
Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum. Br J Haematol. 2020 08; 190(4):e248-e250.
-
Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia. Br J Haematol. 2020 06; 189(6):1054-1056.
-
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism. Haematologica. 2020 06; 105(6):1559-1566.
-
Influence of AS3MT polymorphisms on arsenic metabolism and liver injury in APL patients treated with arsenic trioxide. Toxicol Appl Pharmacol. 2019 09 15; 379:114687.
-
Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line. Eur J Pharmacol. 2019 Mar 05; 846:49-62.
-
Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status. Int J Biochem Cell Biol. 2019 03; 108:7-16.
-
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia. Leukemia. 2019 07; 33(7):1598-1607.
-
Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120. Eur J Pharmacol. 2018 Dec 15; 841:10-18.